NCT04327622View on ClinicalTrials.gov

Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population

CompletedOBSERVATIONAL
Enrollment

5,084

Participants

Timeline

Start Date

March 3, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Foot DeformitiesOnychauxisNeuropathy, DiabeticHyperkeratosisOnychomycosisFoot Ulcer, Diabetic
Trial Locations (1)

Unknown

LMC Healthcare, Toronto

All Listed Sponsors
lead

LMC Diabetes & Endocrinology Ltd.

OTHER

NCT04327622 - Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population | Biotech Hunter | Biotech Hunter